Non-traditional lipid markers such as apolipoprotein A-1 (ApoA-1) may better capture residual cardiovascular and graft risk after kidney transplantation, but data are limited. We studied 2307 kidney transplant recipients in the nationwide Korean Organ Transplantation Registry with stored serum samples. Outcomes were...
Daseul Huh, Juyeon Park, Y. K. Kee et al.· Scientific Reports· 0 citations
BACKGROUND
Yttrium-90 transarterial radioembolization (TARE) combined with immune checkpoint inhibitors has been investigated as a potential therapeutic strategy for advanced hepatocellular carcinoma (HCC); however, evidence supporting its addition to current standard systemic therapy remains limited. We aimed to compa...
Yun-Mi Ko, H. Shin, Moon-Haeng Hur et al.· European Radiology· 0 citations
BACKGROUND
As the role of transarterial radioembolization (TARE) in resectable hepatocellular carcinoma (HCC) beyond Milan criteria remains undefined, this study compared preoperative TARE and chemoembolization (TACE) with primary resection to establish the optimal management strategy.
MATERIALS AND METHODS
We retros...
Jea-Yong Park, G. Lim, Yun-Mi Ko et al.· European Radiology· 0 citations
Background/Aims
Hepatitis delta virus (HDV) coinfection exacerbates clinical outcomes in chronic hepatitis B (CHB) patients. With emerging HDV-targeted therapeutics, accurate prevalence and clinical impact data are essential. In this study, the seroprevalence, clinical significance, and molecular characteristics of HDV...
Min Kyung Park, Yun-Sook Lim, E. Cho et al.· Gut and Liver· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.